Key result
CMR with native T1 and ECV achieves 100% positive predictive value for diagnosing cardiac amyloidosis.
Why the study?
Cardiac amyloidosis is a common yet underdiagnosed cause of heart failure with a hypertrophic phenotype in elderly patients, warranting evaluation of CMR with T1 imaging for diagnostic accuracy.
Does cardiac magnetic resonance imaging accurately diagnose cardiac amyloidosis in elderly patients with symptomatic heart failure and a hypertrophic phenotype?
Observational (n=112)
Does cardiac magnetic resonance imaging accurately diagnose cardiac amyloidosis in elderly patients with symptomatic heart failure and a hypertrophic phenotype?
CMR with T1 mapping and ECV demonstrates high diagnostic accuracy for cardiac amyloidosis in elderly heart failure patients, allowing for a definite diagnosis in 56% of patients and potentially avoiding the need for contrast in a third of patients.
Answers are grounded in this paper and cite their sources.
May aid noninvasive CA diagnosis in elderly HF; extends observational data but leaves open need for validation.
Aims Cardiac amyloidosis (CA) is a common yet underdiagnosed cause of heart failure with hypertrophic phenotype in elderly patients. Cardiac magnetic resonance (CMR) imaging enables myocardial tissue characterization and differentiation of causes for left ventricular (LV) hypertrophy. This study evaluated the diagnostic accuracy of CMR with T1 imaging to detect CA (including transthyretin and light-chain amyloidosis), in patients with symptomatic heart failure and risk factors for CA. Methods and results We prospectively enrolled patients aged ≥ 60 years with symptomatic heart failure, left ventricular (LV) ejection fraction ≥ 40%, increased LV wall thickness, and elevated cardiac biomarkers. All patients underwent standardized CMR, bone scintigraphy with SPECT/CT and screening for monoclonal protein; biopsies were performed if necessary. Among 112 consecutive patients (median age 81 years, 45% female), CA was diagnosed in 38 patients (34%). Diagnostic accuracy was 0.836 for native T1 measurement and 0.904 for extracellular volume fraction (ECV). Combining native T1 (≥1,303ms), ECV (≥37%) and LV mass-to-volume index (≥1.26 g/ml) provided 100% positive predictive value, while native T1 <1,303ms was associated with 100% negative predictive value. This diagnostic algorithm (Figure) allowed a definite diagnosis by CMR in 56%, while 44% required further diagnostics. Contrast application could be avoided in 33% of patients. Conclusion CMR imaging with T1 alterations and LV hypertrophic remodeling demonstrates high diagnostic accuracy for detecting cardiac amyloidosis in elderly patients with heart failure. These findings support broader CMR implementation in evaluating heart failure.
No takes yet. Share an insight, caveat, or question.
Unger et al. (2026) conducted an observational in Symptomatic heart failure with risk factors for cardiac amyloidosis (n=112). Cardiac magnetic resonance (CMR) imaging with T1 mapping and extracellular volume fraction (ECV) was evaluated on Diagnostic accuracy to detect cardiac amyloidosis (Accuracy 0.836 for native T1 and 0.904 for ECV). Cardiac magnetic resonance imaging demonstrated high diagnostic accuracy for detecting cardiac amyloidosis in elderly patients with heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: